MS Contin
What it is used for
Treatment of chronic severe pain of cancer. MS Contin 200mg should only be used in narcotic-tolerant patients. INDICATIONS AS AT 14TH AUGUST 1997: Treatment of opioid responsive, chronic severe pain.,Treatment of chronic severe pain of cancer. MS Contin 200mg should only be used in narcotic-tolerant patients. INDICATIONS AS AT 14TH AUGUST 1997: Treatment of opioid responsive, chronic severe pain.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient morphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is
Visual appearance
Smooth, film coated, teal green biconvex tablets, free from imperfections. Plain on one side and imprinted with the dosage on the other
Images are the copyright of the Pharmacy Guild of Australia
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.